Results 211 to 220 of about 65,144 (350)

Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do's, don't and maybe's. [PDF]

World Allergy Organ J
Bernstein JA, Ansotegui I, Asero R, Banerji A, Betschel S, Craig T, García-Abujeta JL, Gómez RM, Grumach AS, Hide M, Lang DM, Levin M, Longhurst HJ, Maurer M, Morais-Almeida M, Van DN, Pité H, Riedl MA, Rojo Gutiérrez MI, Saini SS, Sussman G, Toubi E, Zanichelli A, Zuraw B, Zuberbier T.   +24 more
europepmc   +1 more source

Circadian Changes in the Inhibitory Effects of an Antihistamine Drug in Man**From the Foundation A. de Rothschild, Service de Dermato-Allergie, 29, rue Manin, Paris, France.

, 1966
Alain Reinberg, E Sidi
openalex   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg, M. Kinberger, B. Arents, N. Aszodi, S. Barbarot, T. Bieber, H. A. Brough, P. Calzavara‐Pinton, S. Christen‐Zaech, M. Deleuran, M. Dittmann, N. Fosse, K. Gáspár, L. A. A. Gerbens, U. Gieler, G. Girolomoni, S. Gregoriou, S. Holland, C. G. Mortz, A. Nast, U. Nygaard, E. M. Rehbinder, J. Ring, M. Rossi, E. Serra‐Baldrich, D. Simon, Z. Z. Szalai, J. C. Szepietowski, A. Torrelo, T. Werfel, R. N. Werner, C. Flohr   +31 more
wiley   +1 more source

ANTIHISTAMINE DRUGS IN PRE-ANAESTHETIC MEDICATION: BLIND STUDIES ON 953 PATIENTS

, 1960
Erwin Lear, Remedios Suntay, Irving M. Pallin, Albert E. Chiron, Herbert J. Fisch, G Abrams   +5 more
openalex   +1 more source

Blocking of histamine‐induced conjunctivitis by the oral antihistamine, astemizole. [PDF]

, 1988
Tanner Stokes, Gavin Feinberg
openalex   +1 more source

Prevalence, treatment and burden of chronic spontaneous urticaria in five European countries

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluates prevalence, treatment patterns, disease profile and burden in patients with chronic spontaneous urticaria (CSU) in five European countries (EU5: France, Germany, Italy, Spain and the United Kingdom [UK]). CU, chronic urticaria; ER, emergency room; GAD, General Anxiety Disorder‐7; HRU, healthcare resource use; HRQoL, health‐related ...
Maria‐Magdalena Balp, Kathryn Krupsky, Shaloo Gupta, Clementine Lienhard, Ravneet K. Kohli, Dhaval Patil, Florence Tétart, John Reed, Tariq El‐Shanawany   +8 more
wiley   +1 more source

Large Volume Leukapheresis in a Patient With Meniere's Disease. [PDF]

J Clin Apher
Cooling L.
europepmc   +1 more source

Synthesis of 5-Diethylaminomethyl-2-substituted-aminothiazoles-their Fungitoxicity, Antispasmodic and Antihistaminic Activities [PDF]

, 1986
Ananya Nayak, S. B. MISRA
openalex   +1 more source

Criteria to Report Adverse Drug Withdrawal Events in Clinical Trials: A Systematic Review

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Polypharmacy is a major risk factor for adverse drug events (ADEs), which are a common cause of hospitalization, especially among older adults. Deprescribing is a promising strategy to prevent ADEs; however, clinicians may hesitate to deprescribe for fear of causing adverse drug withdrawal events (ADWEs). Collectively, ADWEs are the
Jimin J. Lee, Émilie Bortolussi‐Courval, Eva Filosa, Soham Rej, Claire Godard‐Sebillote, Robyn Tamblyn, Todd C. Lee, Emily G. McDonald   +7 more
wiley   +1 more source

Increased prevalence of urticarial diseases and antihistamine/corticosteroid consumption in patients with attention-deficit/hyperactivity disorder. [PDF]

BMJ Ment Health
Magen E, Merzon E, Geishin A, Ashkenazi S, Manor I, Vinker S, Green I, Golan-Cohen A, Weizman A, Israel A.   +9 more
europepmc   +1 more source